Imedex E-learning (audio)

John C. Byrd, MD: Update on BTK inhibitors: Ibrutinib pus the new kids on the block: Are they better?

Informações:

Sinopsis

Webcast: Navigating the Evolving Therapeutic Landscape of CLL: Strategies for the Optimal Application of Emerging Agents and Combinations in Practice